Brexpiprazole versus placebo or other antidepressive agents for treating depression

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To investigate the efficacy, tolerability, acceptability, and safety of brexpiprazole as monotherapy or adjunct treatment in the acute‐ and long‐term treatment of major depression.